Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis

NCT02480946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: MBS2320
DRUG: Placebo
DRUG: Methotrexate

Sponsor

Modern Biosciences Ltd

Collaborators

[object Object]